Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease
Macy L. Early(Johns Hopkins University), Lydia H. Pecker(Johns Hopkins University), Ann Kinga Malinowski(Mount Sinai Hospital), Amy Luo(Johns Hopkins University), Kristine Matusiak(Thrombosis and Atherosclerosis Research Institute), Ahizechukwu C. Eke(Johns Hopkins University), Nadine Shehata(Mount Sinai Hospital), Maidah Raja(Johns Hopkins University), Kevin H.M. Kuo(University Health Network), Sophie Lanzkron(Thomas Jefferson University), Marissa Solow(University Health Network)
Cited by 4
Related Papers
Management of Sickle Cell Disease
|JAMA|2014|1.6k
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members
|Survey of Anesthesiology|2015|270